$37.62
-0.48 (-1.26%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+43.81%
1Y
+135.13%
YTD
+45.19%
Open$37.36
Previous Close$38.10
Day High$38.90
Day Low$37.36
52W High$36.29
52W Low$14.32
Volume—
Avg Volume1.55M
Market Cap7.26B
P/E Ratio—
EPS$-2.77
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.99
Above
SMA 200
$19.59
Above
RSI (14)
49.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+62.0% upside
Current
$37.62
$37.62
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.40B | 1.44B | 1.30B |
| Net Income | 261.90M | 339.04M | 251.92M |
| Profit Margin | 18.7% | 23.6% | 19.4% |
| EBITDA | 403.28M | 390.65M | 352.93M |
| Free Cash Flow | 259.22M | 284.01M | 237.35M |
| Rev Growth | +1.7% | -7.0% | +15.8% |
| Debt/Equity | 0.75 | 0.69 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |